ArticleFrontiers in human neuroscience2026
Effects of anti-parkinsonian medication on gait during internal and external rhythmic auditory cueing in PD.
Article in Frontiers in human neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: External and internal auditory cueing strategies improve gait function, including velocity and stride length, in people with Parkinson disease (PD). Further, internal cueing can reduce gait variability, a measure associated with falls. In the present study, we asked whether the efficacy of external and internal rhythmic cues depends on dopaminergic status, i.e., OFF vs. ON medication. This question is relevant to the real-world use of cueing, as dopaminergic medication responsiveness fluctuates for individuals. We measured gait while participants with PD walked with an external cue (music playing aloud) and with an internal cue (mentally singing) in both OFF and ON medication states. We hypothesized both cues would improve gait regardless of medication status. Methods: Participants ( Results: Medication improved spatial measures of gait but did not change cadence. Both Music and Mental singing increased velocity, stride length, and cadence. For measures of linear variability, Music trials had statistically higher variability than Mental trials. There was an interaction effect between medication and cueing condition for double limb support; in the OFF-medication state, Music had longer double support times than Uncued and Mental singing. Conclusion: Cueing strategies improved gait regardless of medication status, suggesting they may be useful throughout the day despite medication fluctuations. However, internally-based mental singing cues produced greater benefits than external music cues, in both the ON and OFF state, for measures of gait variability. Further investigation of the efficacy of cues within and across anti-PD medication cycles would be helpful to understand their utility in the real world.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.